methylatropine
This page covers all methylatropine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor DM1, Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2.
Targets
Phase 2 pipeline (1)
- Methylatropinium · Neuroscience
Methylatropinium works by blocking the action of acetylcholine, a neurotransmitter that helps transmit signals in the nervous system.
Patent intelligence
- methylatropine patent landscape — aggregated cliff calendar, attackable patents, originator estates